Clinical Trial

Efficacy and Safety of Combination Therapy of Sintilimab and Chemotherapy With Cryoablation in NSCLC

Name: Efficacy and Safety of Combination Therapy of Sintilimab and Chemotherapy With Cryoablation in NSCLC — clinical trial record (NCT06483009)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

This study aims to investigate the efficacy and safety of immuno-chemotherapy in combination of cryoablation as the first-line treatment of advanced NSCLC

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2024-06-27.

Trial Details

NCT Number	NCT06483009
Lead Sponsor	Shanghai Chest Hospital
Conditions	Non-Small-Cell Lung Cancer
Enrollment	20 participants
Start Date	2024-10
Primary Completion	2027-10 (estimated)
Study Completion	2027-10 (estimated)
Updated on ClinicalTrials.gov	2024-08-30